New Zealand markets open in 3 hours 45 minutes

9 Meters Biopharma, Inc. (2Q3A.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.01230.0000 (0.00%)
At close: 02:20PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
32,439
31,008
21,995
10,933
13,716
Selling general and administrative
11,001
11,009
9,663
10,520
10,567
Total operating expenses
43,440
42,017
31,658
21,453
24,283
Operating income or loss
-43,440
-42,017
-31,658
-21,453
-24,283
Interest expense
3,420
2,667
47.188
4,046
1,825
Total other income/expenses net
-
416.697
-5,097
-36,016
-1,126
Income before tax
-46,283
-43,766
-36,779
-61,496
-27,049
Income tax expense
0
0
0
0
0
Income from continuing operations
-46,283
-43,766
-36,779
-61,496
-27,049
Net income
-46,283
-43,766
-36,779
-61,496
-27,049
Net income available to common shareholders
-46,283
-43,766
-36,779
-61,496
-27,049
Basic EPS
-
-3.38
-3.03
-11.60
-16.20
Diluted EPS
-
-3.38
-3.03
-11.60
-16.20
Basic average shares
-
12,956
12,155
5,282
1,666
Diluted average shares
-
12,956
12,155
5,282
1,666